Market Analysis and Insights: Global Injectable Drug Delivery Market
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global Injectable Drug Delivery market size is projected to reach US$ 675.5 million by 2030, from US$ 421.2 million in 2022, at a CAGR of 6.5% during 2023-2030.
North America is expected to dominate the market in 2018, Asia is expected to grow at the highest CAGR during the forecast period. This growth in this market is attributed to rising incidence of chronic diseases and growing aging population. In addition, high penetration of self-injection technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Drug Delivery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Drug Delivery market.
Global Injectable Drug Delivery Scope and Market Size
Injectable Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.
Segment by Type
Skin Injection
Circulatory/Musculoskeletal Injection
Organs Injection
Central Nervous System Injection
Segment by Application
Hospitals & Clinics
Home Care Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
